Browsing: drug

Taipei, Aug. 6 (CNA) Weight-loss injections based on GLP-1 receptor agonists were associated with a 41 percent lower risk of developing 13 obesity-related cancers than weight loss achieved through diet and exercise alone, according to a National Taiwan University Hospital (NTUH) study

Dual designations support development of a potential first disease-modifying therapy for an ultra-rare neurometabolic disorder

Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in

Pharmaceutical firm Eli Lilly has reported a doubling in global sales for its diabetes and weight loss injection Mounjaro, fuelled by surging market appetite

Amgen (NASDAQ:AMGN), the biotech heavyweight behind treatments for cancer, cardiovascular disease and other serious illnesses, gave investors another reason to cheer after posting a stronger-than-expected second quarter. Reuters reported revenue climbed 9% year over year to about $10.05 billion, while adjusted earnings landed at $6.29 per share, comfortably ahead of the $5.62 Wall Street consensus.…

Eli Lilly (NYSE:LLY | LLY Price Prediction) opened Wednesday’s session with a blowout second-quarter earnings report, sending shares sharply higher and cementing the drugmaker’s status as the only pharmaceutical company trading above a $1 trillion market cap. On a CNBC segment breaking down the release, anchor Joe Kernen walked viewers through the headline figures that…

Pfizer has halted a trial of an obesity drug that applied D&D Pharmatech’s (347850) oral peptide platform “Oralink.”

Six hundred veterans will participate in a new clinical trial to determine whether a popular prescription drug for diabetes and weight loss can treat alcohol use disorder, or AUD

Researchers developing a new weight loss drug are looking for people to take part in clinical trials in Bradford

[Sportschosun, Jang Jong-ho] A recent animal study has found that tirzepatide, which is increasingly being used as an obesity treatment, improves weight, fatty liver and blood sugar levels, but does not sufficiently reduce inflammation and fibrosis in adipose tissue